Cargando…
Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
AIM: Gastrointestinal discomfort is the most common adverse event in metformin treatment for type 2 diabetes. The mechanism of action of metformin is associated with gut microbiota. However, the gut microbial community structure related to metformin-induced gastrointestinal adverse events remains un...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714661/ https://www.ncbi.nlm.nih.gov/pubmed/36465607 http://dx.doi.org/10.3389/fendo.2022.1044030 |